LABCORP HOLDINGS INC.

LH · Mid cap · 1 article

Financial highlights

Metric	FY 12/31/25	FY 12/31/24	FY 12/31/23	FY 12/31/22	FY 12/31/21
Income Statement
Revenue	$14.0B	$13.0B	$12.2B	$11.9B	$13.1B
Cost of revenue	$9.9B	$9.4B	$8.8B	$8.2B	$8.1B
Gross profit	$4.0B	$3.6B	$3.4B	$3.7B	$5.0B
Selling, general & administrative	$2.2B	$2.2B	$2.0B	$1.8B	$1.7B
Operating income	$1.4B	$1.1B	$725.6M	$1.4B	$3.0B
Interest expense	$224.1M	$208.3M	$199.6M	$179.8M	$211.8M
Income tax expense	$229.8M	$212.4M	$188.5M	$233.9M	$690.0M
Net income	$876.5M	$746.0M	$418.0M	$1.3B	$2.4B
Balance Sheet
Cash and equivalents	$532.3M	$1.5B	$536.8M	$320.6M	$1.5B
Current assets	$4.0B	$4.8B	$3.8B	$4.6B	$5.3B
Total assets	$18.4B	$18.4B	$16.7B	$20.2B	$20.4B
Current liabilities	$2.8B	$3.3B	$3.2B	$3.1B	$2.8B
Total liabilities	$9.8B	$10.3B	$8.8B	$10.0B	$10.1B
Stockholders' equity	$8.6B	$8.1B	$7.9B	$10.1B	$10.3B
Cash Flow Statement
Cash from operations	$1.6B	$1.6B	$1.3B	$2.0B	$3.1B
Depreciation and amortization	$681.1M	$643.5M	$577.3M	$537.2M	$577.0M
Stock-based compensation	$125.8M	$116.7M	$128.7M	$116.8M	$132.9M
Capital expenditure	$434.5M	$489.9M	$453.6M	$429.3M	$421.5M
Free cash flow	$1.2B	$1.1B	$874.1M	$1.5B	$2.7B
Dividends paid	$240.7M	$243.1M	$254.0M	$195.2M	$0
Share repurchases	$450.0M	$250.1M	$1.0B	$1.1B	$1.7B
Impairments	$4.3M	$5.3M	$349.0M	$261.7M	$0

Shares outstanding 82.0M · Free float 94.5%

Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.